首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 187 毫秒
1.
目的观察维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶治疗寻常痤疮的临床疗效。方法 96例患者随机分为治疗组和对照组各48例,治疗组采用维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶外用治疗,对照组仅外用5%过氧苯甲酰凝胶治疗。观察2组疗效。结果治疗组总有效率为91.7%高于对照组的64.6%,差异有统计学意义(P<0.05)。结论维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶治疗寻常痤疮疗效满意。  相似文献   

2.
目的 观察维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶治疗寻常痤疮的临床疗效.方法 96例患者随机分为治疗组和对照组各48例,治疗组采用维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶外用治疗,对照组仅外用5%过氧苯甲酰凝胶治疗.观察2组疗效.结果 治疗组总有效率为91.7%高于对照组的64.6%,差异有统计学意义(P<0.05).结论维胺酯维生素E乳膏联合5%过氧苯甲酰凝胶治疗寻常痤疮疗效满意.  相似文献   

3.
目的观察异维A酸红霉素凝胶联合过氧苯甲酰凝胶治疗中、重度痤疮的疗效。方法将201例Ⅱ~Ⅳ度寻常痤疮患者随机分为2组,治疗组106例,对照组95例。治疗组予异维A酸红霉素凝胶联合过氧苯甲酰凝胶,对照组给予异维A酸红霉素凝胶治疗。每2周随访1次,观察疗效及不良反应,8周后进行治疗评定。结果治疗组痊愈率和有效率(58.49%、96.23%)高于对照组(36.84%、88.42%)。结论异维A酸红霉素凝胶联合过氧苯甲酰凝胶治疗中、重度痤疮较单纯外用异维A酸红霉素凝胶疗效好。  相似文献   

4.
目的:通过阿达帕林凝胶与5%过氧苯甲酰霜对寻常性痤疮治疗的对照观察,评价阿达帕林凝胶治疗寻常性痤疮的疗效和安全性.方法:采用开放对照临床实验,分别应用阿达帕林凝胶与5%过氧苯甲酰霜对寻常性痤疮病人进行治疗,疗程12周,在治疗的2、4、8和12周进行随访.结果:阿达帕林凝胶治疗寻常性痤疮疗效和安全性均高于5%过氧苯甲酰霜剂.结论:阿达帕林凝胶是治疗寻常性痤疮安全和有效的药物.  相似文献   

5.
黄玲  黄静 《安徽医药》2008,12(5):454-455
目的探讨克痤隐酮凝胶治疗寻常痤疮的临床疗效。方法92例随机分为两组,治疗组予克痤隐酮凝胶外用,对照组予5%过氧苯甲酰凝胶外用。结果两组患者炎性皮损数目较非炎性皮损数目明显减少;克痤隐酮凝胶治疗寻常痤疮的有效率为83.33%,5%过氧苯甲酰凝胶治疗寻常痤疮的有效率为84.09%,两组有效率差异无显著性(P〉0.05)。结论克痤隐酮凝胶治疗寻常痤疮和5%过氧苯甲酰凝胶同样有效。  相似文献   

6.
目的评价复方芙蓉叶酊治疗74例寻常型痤疮的临床疗效。方法试验组用复方芙蓉叶酊外用治疗寻常型痤疮74例,对照组用5%过氧苯甲酰凝胶治疗73例,分别于治疗前及治疗后4、8周记录皮损数以判定疗效。结果两组总有效率对比无显著性差异(P>0.05)。结论复方芙蓉叶酊是治疗寻常型痤疮的有效药物。  相似文献   

7.
目的观察维胺脂维E乳膏与氧氟沙星凝胶合用治疗寻常痤疮的疗效。方法对110例寻常痤疮患者采用维胺脂维E乳膏与氧氟沙星凝胶联合外用,并与215例单用维胺脂维E乳膏寻常痤疮患者及53例单用5%过氧苯甲酰乳膏寻常痤疮患者进行了临床疗效对照。结果治疗组痊愈率为27.3%,总有效率为100%。与对照组比较差异有统计学意义(χ2=10.9,10.71,P〈0.01)。结论维胺脂维E乳膏与氧氟沙星凝胶合用治疗寻常痤疮的疗效满意。  相似文献   

8.
目的:观察5%过氧苯甲酰凝胶治疗酒渣鼻的临床疗效和不良反应.方法:采用5%过氧化苯甲酰凝胶,每日2次,早晚洗脸后薄涂于患处,6周为1疗程,连续用药1-2个疗程.观察12周.结果:临床疗效,痊愈22例,显效18例,好转6例,无效4例,有效率为80%.结论:过氧苯甲酰凝胶治疗酒渣鼻有较好效果和耐受性.  相似文献   

9.
目的:将制备的复方过氧苯甲酰乳膏制剂进行临床疗效观察,考察其对治疗痤疮的有效性。方法:以过氧苯甲酰和甲硝唑为主药制成乳膏,用于治疗痤疮,并以维胺酯维E乳膏作为对照组观察临床疗效。结果:治疗组总有效率93.3%,对照组总有效率77.8%,两组差异有显著性(P<0.05),治疗组优于对照组。结论:复方过氧苯甲酰乳膏制备工艺可行,质量稳定,疗效确切,无不良反应。  相似文献   

10.
目的 临床观察红蓝光照射治疗中重度痤疮的疗效.方法 治疗组予以红蓝光交替照射面部皮损,配合口服丹参酮、外用克林霉素甲硝唑搽剂及5%过氧苯甲酰凝胶,对照组仅药物治疗.结果 配合红蓝光照射治疗中重度痤疮的有效率明显高于传统药物治疗.结论 红蓝光照射治疗中重度痤疮可大大提高临床疗效.  相似文献   

11.
BACKGROUND: Acne vulgaris is a common skin disease that affects 70 to 96% of individuals. Topical benzoyl peroxide has been used successfully for acne treatment; however, it may be accompanied by drying and or flaking skin. The addition of a 10% urea to the product excipient is theorized to moisturize the skin due to its humectant properties, aid in the efficacy of benzoyl peroxide due to its keratolytic properties, and effectively combat Propionibacterium acnes due to its antibacterial properties. OBJECTIVE: To assess the efficacy and tolerability of the treatment of acne vulgaris with multiple strengths of benzoyl peroxide in a 10% urea vehicle gel or cream and cleanser. Methods: A multicenter, non-randomized, open-label study in which 1,089 patients with acne vulgaris were enrolled at 133 participating physician office sites. Qualifying and consenting patients were prescribed either 4.5% or 8.5% benzoyl peroxide in a 10% urea vehicle cream or gel and cleanser. Additional medications were permitted during the study with the exception of those containing benzoyl peroxide. The physician assessed lesion counts, both inflammatory and non-inflammatory, at baseline and Week 4. Dryness and erythema were rated by the physician on a scale from 0 (none) to 8 (severe or deep) at baseline and Week 4. RESULTS: Nine hundred sixty-three patients completed the study. The following significant treatment arms were analyzed: patients treated with 4.5%/8.5% benzoyl peroxide in a 10% urea vehicle product only, patients treated with 4.5%/8.5% benzoyl peroxide in a 10% urea vehicle products along with oral doxycycline, and patients treated with 4.5%/8.5% benzoyl peroxide in a 10% urea vehicle products along with oral minocycline. A 44% (n=567) mean reduction in total lesion count was observed after 4 weeks of treatment with 4.5%/8.5% benzoyl peroxide in a 10% urea vehicle products only. Dual therapy using oral doxycycline (n=17) proved to be even more effective with a significant mean reduction in lesion count of 52% after only 4 weeks of treatment. Dual therapy using oral minocycline (n=21) yielded a significant mean reduction in lesion count of 34% after 14 weeks of treatment. The overall tolerability of the treatment illustrated the utility of urea as a moisturizing agent. CONCLUSION: Benzoyl peroxide in a 10% urea vehicle gel or cream and cleanser, used once daily for 4 weeks was found to be both effective and well tolerated for the treatment of symptoms related to acne vulgaris.  相似文献   

12.
BACKGROUND: Benzoyl peroxide (BPO) is poorly soluble. A solubilized formulation of BPO has been developed to maximize its bioavailability and enhance follicular penetration. METHODS: Patients with acne vulgaris were randomly assigned to receive solubilized BPO 5% gel on one side of the face and a BPO 5%/clindamycin 1% combination product on the contralateral side, twice daily for 4 weeks. RESULTS: Of 23 patients enrolled, 100% completed the study. Reductions in lesion count with the solubilized BPO gel were at least as great as with BPO/clindamycin--and significantly greater (P< or =.05) for noninflammatory lesions at week 1 and inflammatory lesions at week 4. Both regimens were generally well tolerated and patient satisfaction was comparable. CONCLUSIONS: Solubilized BPO 5% gel monotherapy offers significantly greater efficacy, and comparable patient satisfaction, compared with BPO/clindamycin. The early reduction in lesion counts observed with the solubilized BPO gel in the absence of an antibiotic is clinically relevant.  相似文献   

13.
杨姜德  张述华  卢圆圆 《中国药房》2010,(28):2664-2665
目的:观察新癀片联合阿奇霉素、0.1%阿达帕林凝胶治疗寻常型痤疮的疗效。方法:将216例Ⅰ、Ⅱ度寻常型痤疮患者根据就诊顺序随机分为治疗组和对照组各108例。治疗组应用新癀片、阿奇霉素口服加外用0.1%阿达帕林凝胶进行治疗;对照组应用红霉素肠溶片口服加外用复方硫磺洗剂。疗程满6周后观察2组疗效。结果:治疗组总有效率为97.2%,对照组总有效率为41.6%,2组比较有显著性差异(P<0.01)。在6周的临床试验中,治疗组的不良反应发生率明显低于对照组(P<0.05)。结论:新癀片联合阿奇霉素、0.1%阿达帕林凝胶治疗Ⅰ、Ⅱ度寻常型痤疮可明显缓解病情、缩短病程,且不良反应轻微。  相似文献   

14.
目的观察一清胶囊联合复方氯霉素洗剂治疗寻常型痤疮的临床疗效。方法选择门诊寻常型座疮患者96例,随机分为两组。治疗组患者口服一清胶囊每次2g,3次/d,复方氯霉素洗剂外用患处,2次/d。对照组患者口服盐酸四环素片每次0.25g,4次/d,2周后改为每次0.25g,2次/d,复方氯霉素洗剂外用患处,2次/d。两组疗程均为1个月。结果治疗组和对照组治疗后1个月的总有效率分别为91.67%和77.08%,两组比较差异有统计学意义(χ2=3.87,P<0.05)。结论一清胶囊联合复方氯霉素洗剂治疗寻常型座疮是安全有效的,值得临床推广使用。  相似文献   

15.
目的 评价0.05%异维A酸凝胶(抗面部痤疮药)治疗寻常痤疮的疗效及安全性.方法 用多中心随机双盲安慰剂对照试验设计,以凝胶基质为对照,2药分别外用患处,每日2次,疗程12周.结果 0.05%异维A酸凝胶与凝胶基质比较,治疗寻常痤疮的有效率分别为78.5%和23.3%;2药的药物不良反应发生率分别为23.2%和15.6%(P>0.05).结论 0.05%异维A酸凝胶治疗寻常痤疮是安全有效的外用药物.  相似文献   

16.
Topical acne therapies are widely used for the treatment of mild to moderately severe acne vulgaris. However, many available treatments have limitations associated with their use, including lengthy time to response, cosmetic acceptability, and photosensitivity. Combinations of topical antibiotics and comedolytics are especially useful, but some formulations have stability challenges. A new combination formulation that contains 1% clindamycin and 5% benzoyl peroxide (BenzaClin Topical Gel) is currently available. In clinical trials, clinical improvement occurred at the first two follow-up visits and continued throughout treatment. In addition, combination therapy with clindamycin/benzoyl peroxide gel rapidly reduces Propionibacteria acnes counts and suppresses the emergence of clindamycin-resistant P. acnes. This formulation is stable at room temperature for up to 2 months after compounding. The aqueous gel vehicle is less drying, and there is no photosensitivity associated with its use. This study compares the combination treatment of 1% clindamycin and 5% benzoyl peroxide topical gel with other therapeutic options for mild to moderately severe acne vulgaris.  相似文献   

17.
18.
目的:探讨异维A酸胶丸联合百癣夏塔热片治疗中重度寻常型痤疮的临床效果。方法:采用随机、平行、对照的临床试验,将78例受试对象随机分为对照组和治疗组;对照组30例常规使用异维A酸胶丸口服治疗,治疗组48例在上述治疗基础上联合百癣夏塔热片治疗,两组均外用克林霉素凝胶和0.025%迪维霜。疗程为6周,结束后观察疗效。结果:治疗组总有效率为89.58%,痊愈率为62.50%;对照组总有效率为66.67%,痊愈率为40.00%,两组疗效比较差异有统计学意义(P〈0.05)。结论:异维A酸胶丸联合百癣夏塔热片治疗中重度寻常型痤疮有较好的疗效,值得临床使用。  相似文献   

19.
苏琼华 《中国药房》2009,(3):221-222
目的:研究丹参酮胶囊、功劳去火片治疗寻常性痤疮的经济学效果。方法:采用成本-效果分析法,以60例患者为对象,对2种治疗方案进行经济学评价。结果:2种治疗方案总有效率分别为93.33%和96.67%;成本分别为354.14和212.94元;成本-效果比分别为3.79和2.20。结论:功劳去火片治疗寻常性痤疮较为经济。  相似文献   

20.
Benzoyl peroxide (BP) has been a standard and effective topical treatment for acne vulgaris for the past 35 years. Previous studies and case reports have documented benzoyl peroxide to be a strong irritant and a weak allergen, with many cases of tolerance induced with repeat use of this irritant. While less common, numerous cases of BP-induced allergic contact dermatitis (delayed type hypersensitivity reaction) have been reported in the literature. We report here an individual with an incipient edematous reaction to topical BP used for acne therapy. This under-recognized presentation is discussed in the context of published literature on BP-induced hypersensitivity and irritation.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号